Design Issues in a Prospective Randomized Double-Blinded Trial of Prophylaxis with Fluconazole versus Voriconazole after Allogeneic Hematopoietic Cell Transplantation

Hematopoietic Cell ◽

Design Issues ◽

Double Blinded ◽

Blinded Trial

Faculty Opinions recommendation of Reduced-intensity conditioning followed by allogeneic hematopoietic cell transplantation for adult patients with myelodysplastic syndrome and myeloproliferative disorders.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1099175.555390 ◽

2008 ◽

Author(s):

Francesco Onida

Keyword(s):

Myelodysplastic Syndrome ◽

Cell Transplantation ◽

Myeloproliferative Disorders ◽

Hematopoietic Cell ◽

Adult Patients ◽

Reduced Intensity Conditioning ◽

Reduced Intensity

Faculty Opinions recommendation of Pretransplant CSF-1 therapy expands recipient macrophages and ameliorates GVHD after allogeneic hematopoietic cell transplantation.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.11545956.12638054 ◽

2011 ◽

Author(s):

Bruce Blazar ◽

Christoph Bucher

Keyword(s):

Cell Transplantation ◽

Allogeneic Hematopoietic Cell Transplantation

Hematopoietic Cell ◽

Faculty of 1000 evaluation for Intermittent Zolendronic Acid Prevents Bone Loss in Adults after Allogeneic Hematopoietic Cell Transplantation.

F1000 - Post-publication peer review of the biomedical literature ◽

10.3410/f.718023531.793480622 ◽

2013 ◽

Author(s):

Tim Cundy

Keyword(s):

Bone Loss ◽

Cell Transplantation ◽

Hematopoietic Cell ◽

Zolendronic Acid

Inhibition of Biomarker ST2 by Small Molecules Improves Survival in Allogeneic Hematopoietic Cell Transplantation

SSRN Electronic Journal ◽

10.2139/ssrn.3155805 ◽

2018 ◽

Author(s):

Abdulraouf M. Ramadan ◽

Etienne Daguindau ◽

Jason C. Rech ◽

Krishnapriya Chinnaswamy ◽

Jilu Zhang ◽

...

Keyword(s):

Small Molecules ◽

Cell Transplantation ◽

Allogeneic Hematopoietic Cell Transplantation

Hematopoietic Cell ◽

Impact of Palifermin on Transplant Outcomes in Children and Adolescents Undergoing Allogeneic Hematopoietic Cell Transplantation

Anticancer Research ◽

10.21873/anticanres.14677 ◽

2020 ◽

Vol 40 (11) ◽

pp. 6531-6537

Author(s):

KRZYSZTOF CZYŻEWSKI ◽

ROBERT DĘBSKI ◽

NATALIA BARTOSZEWICZ ◽

EWA DEMIDOWICZ ◽

MONIKA RICHERT-PRZYGOŃSKA ◽

...

Keyword(s):

Children And Adolescents ◽

Cell Transplantation ◽

Hematopoietic Cell ◽

Transplant Outcomes

Dynamic of plasma IL-22 level is an indicator of thymic output after allogeneic hematopoietic cell transplantation

Life Sciences ◽

10.1016/j.lfs.2020.118849 ◽

2021 ◽

Vol 265 ◽

pp. 118849

Author(s):

Longmei Shang ◽

Maxwell Duah ◽

Yan Xu ◽

Yiwen Liang ◽

Dong Wang ◽

...

Keyword(s):

Cell Transplantation ◽

Hematopoietic Cell ◽

Thymic Output

Impact of depth of clinical response on outcomes of acute myeloid leukemia patients in first complete remission who undergo allogeneic hematopoietic cell transplantation

Bone Marrow Transplantation ◽

10.1038/s41409-021-01261-6 ◽

2021 ◽

Author(s):

Mary-Elizabeth Percival ◽

Hai-Lin Wang ◽

Mei-Jie Zhang ◽

Wael Saber ◽

Marcos de Lima ◽

...

Keyword(s):

Acute Myeloid Leukemia ◽

Complete Remission ◽

Clinical Response ◽

Cell Transplantation ◽

Myeloid Leukemia ◽

Hematopoietic Cell ◽

First Complete Remission ◽

Acute Myeloid

Does Mixed Chimerism after Allogeneic Hematopoietic cell Transplantation in Pediatric Patients with Fanconi Anemia Impact on Outcome?

Transplantation and Cellular Therapy ◽

10.1016/j.jtct.2020.11.024 ◽

2020 ◽

Author(s):

Mouhab Ayas ◽

Khawar Siddiqui ◽

Abdullah Al-Jefri ◽

Ali Al-Ahmari ◽

Ibrahim Ghemlas ◽

...

Keyword(s):

Cell Transplantation ◽

Fanconi Anemia ◽

Pediatric Patients ◽

Hematopoietic Cell ◽

Mixed Chimerism

Successful venetoclax and Actinomycin D-based treatment for relapsed acute myeloid leukemia post allogeneic hematopoietic cell transplantation

Bone Marrow Transplantation ◽

10.1038/s41409-021-01434-3 ◽

2021 ◽

Author(s):

Iman Abou Dalle ◽

Ali Bazarbachi

Keyword(s):

Acute Myeloid Leukemia ◽

Cell Transplantation ◽

Myeloid Leukemia ◽

Actinomycin D ◽

Hematopoietic Cell ◽

Relapsed Acute Myeloid Leukemia ◽

Acute Myeloid

Corrigendum to ‘Ixazomib for chronic Graft-Versus-Host Disease prophylaxis following allogeneic hematopoietic cell transplantation’ [Biology of Blood and Marrow Transplantation 26/10 (2020) 1876-1885]

Transplantation and Cellular Therapy ◽

10.1016/j.jtct.2021.01.005 ◽

2021 ◽

Author(s):

Saurabh Chhabra ◽

Alexis Visotcky ◽

Marcelo C. Pasquini ◽

Fenlu Zhu ◽

Xiaoying Tang ◽

...

Keyword(s):

Cell Transplantation ◽

Graft Versus Host Disease ◽

Marrow Transplantation ◽

Hematopoietic Cell ◽

Host Disease ◽

Graft Versus Host ◽

Blood And Marrow Transplantation